Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Human Papillomavirus Vaccine
100%
Precancerous
100%
Genital Warts
100%
Germany
42%
Uptake Rate
42%
Human Papillomavirus Types
42%
Cervical Cancer
28%
Anogenital
28%
Meta-analysis
14%
Population-based
14%
High Risk
14%
Vaccination
14%
Head-and-neck Cancer
14%
Malignant Tumor
14%
European Countries
14%
Precancerous Lesions
14%
Highly Effective
14%
Epithelial Cells
14%
Vaccination Program
14%
Papillomavirus Infections
14%
Benign Tumor
14%
School-based
14%
Vulvar Cancer
14%
Vaginal Cancer
14%
18 Years Old
14%
Systematic Meta-analysis
14%
Standing Committee on Vaccination (STIKO)
14%
Sexually Transmitted
14%
Sexual Contact
14%
Anogenital Cancer
14%
Anal Cancer
14%
Cervical Cancer Incidence
14%
Vaccine Uptake
14%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
14%
Skin Warts
14%
Sexually Transmitted Virus
14%
Medicine and Dentistry
Wart Virus
100%
Genital Wart
100%
Cervical Cancer
21%
Uptake Rates
21%
Wart Virus Vaccine
14%
Meta-Analysis
7%
Systematic Review
7%
Malignant Neoplasm
7%
Cancer
7%
Virus
7%
Cancer Incidence
7%
Head and Neck Cancer
7%
Precancerous Condition
7%
Epithelial Cell
7%
Papillomavirus Infection
7%
Benign Tumor
7%
Verruca Vulgaris
7%
Vagina Cancer
7%
Anal Cancer
7%
Oropharynx Carcinoma
7%